Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-22-006827
Filing Date
2022-03-21
Accepted
2022-03-21 16:05:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A arav20220318_defa14a.htm DEFA14A 53451
2 aravive01.jpg GRAPHIC 4080
  Complete submission text file 0001437749-22-006827.txt   60254
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36361 | Film No.: 22755769
SIC: 2834 Pharmaceutical Preparations